Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nexalin Technology, Inc. (NXL : NSDQ)

• Company Description    Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $1.09 Daily Weekly Monthly 20 Day Moving Average: 68,393 shares Shares Outstanding: 7.28 (millions) Market Capitalization: $7.94 (millions) Beta: 52 Week High: $3.23 52 Week Low: $0.65 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.91% 2.29% 12 Week 39.56% 35.79% Year To Date 45.53% 41.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1776 Yorktown Suite 550 - Houston,TX 77056 USA ph: 281-830-8900 fax: - nxl@crescendo-ir.com http://www.nexalin.com

• General Corporate Information    Officers Mark White - President and Chief Executive Officer Marilyn Elson - Chief Financial Officer Rick Morad - Director Alan Kazden - Director Ben Hu - Director Peer Information Nexalin Technology, Inc. (EVOL) Nexalin Technology, Inc. (RAMP) Nexalin Technology, Inc. (ALOT) Nexalin Technology, Inc. (TGHI) Nexalin Technology, Inc. (GNCMA) Nexalin Technology, Inc. (GSIC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 65345B201 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/22 Next Expected EPS Date: 03/23/23 Share - Related Items Shares Outstanding: 7.28 Most Recent Split Date: (:1) Beta: Market Capitalization: $7.94 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/23/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.25 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 873.74% vs. Previous Quarter: -% ROE 12/31/22 - - 09/30/22 - - 06/30/22 - - ROA 12/31/22 - - 09/30/22 - - 06/30/22 - - Current Ratio 12/31/22 - - 09/30/22 - 4.21 06/30/22 - - Quick Ratio 12/31/22 - - 09/30/22 - 4.14 06/30/22 - - Operating Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Net Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Pre-Tax Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Book Value 12/31/22 - - 09/30/22 - 0.87 06/30/22 - - Inventory Turnover 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Equity 12/31/22 - - 09/30/22 - 0.00 06/30/22 - - Debt-to-Capital 12/31/22 - - 09/30/22 - 0.00 06/30/22 - -

Powered by Zacks Investment Research ©